Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations

by Zhang R, Li Y, Nie X, Dong X, Wu G
Published 2016-01-01

Advances in the Research of Autophagy in EGFR-TKI Treatment and Resistance 
in Lung Cancer

by Qicheng ZHANG, Ke XU
Published 2016-09-01

Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs

by Chia-Hao Chang, Chih-Hsin Lee, Chih-Hsin Lee, Jen-Chung Ko, Lih-Yu Chang, Ming-Chia Lee, Ming-Chia Lee, Jun-Fu Zhang, Jann-Yuan Wang, Jin-Yuan Shih, Chong-Jen Yu
Published 2020-10-01

Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review

by Chen S, He Y, Liu J, Chen X, Yu J, Li W, Chen B, Sun C, Zhou C
Published 2019-12-01

Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis

by Limin CHEN, Mengjiao FU, Jianya ZHOU, Yinan YAO, Jianying ZHOU
Published 2019-05-01

Next‐generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non‐small cell lung cancer

by Yujun Zhang, Liwen Xiong, Fangfang Xie, Xiaoxuan Zheng, Ying Li, Lei Zhu, Jiayuan Sun
Published 2021-07-01

Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy

by Yulong Fu, Yulong Fu, Anqi Wang, Anqi Wang, Jieqi Zhou, Jieqi Zhou, Wei Feng, Minhua Shi, Xiao Xu, Hongqing Zhao, Liming Cai, Jian Feng, Xuedong Lv, Xiaodong Zhang, Wenjing Xu, Zhengrong Zhang, Guoer Ma, Jian Wang, Tong Zhou, Dahai Zhao, Haohui Fang, Zeyi Liu, Zeyi Liu, Zeyi Liu, Jian-an Huang, Jian-an Huang, Jian-an Huang
Published 2021-02-01

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI

by Guo-Hao Xia, Yun Zeng, Ying Fang, Shao-Rong Yu, Li Wang, Mei-Qi Shi, Wei-Li Sun, Xin-En Huang, Jia Chen, Ji-Feng Feng
Published 2014-12-01

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

by Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J
Published 2021-01-01

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling

by Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J
Published 2020-10-01